Trial Profile
A randomised, multi-centre, double-blind, balanced, parallel group placebo-controlled study of AGI004 for the control of chemotherapy-induced diarrhoea.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Aug 2013
Price :
$35
*
At a glance
- Drugs Mecamylamine (Primary)
- Indications Diarrhoea
- Focus Therapeutic Use
- Sponsors AGI Therapeutics
- 18 Aug 2011 New trial record